AI Company Market Strategy Reports powered by LLM Authority Index. Each report shows how AI systems surface, compare, and recommend your specific brand — with remediation priorities for AEO, citation architecture, and SEO visibility.
Independent market intelligence - Not case studies
SHOWING 1-6 OF 6

PolyPeptide Group’s June 2026 benchmark shows strong recognition in peptide API manufacturing, but weaker conversion from mention to recommendation.

CSBio shows limited visibility in peptide API manufacturing, with one valid recommendation and no top-3 placements.

CPC Scientific appears in peptide API manufacturing benchmarks, with broad mention presence but limited shortlist conversion.

CordenPharma Peptides is visible in peptide API manufacturing queries but does not reach recommendation-stage placement.

See where Biosynth Peptide Division appears, earns recommendations, and loses visibility across AI search results for Peptide API Manufacturing.

AmbioPharm is benchmarked against peptide manufacturing competitors across six AI platforms, showing strong shortlist visibility, limited rank-1 control, and.
Bring this to your own market
Request an AI Visibility Audit and we'll show you where AI systems are recommending — and overlooking — your brand, and what to fix first.